Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Princeton, United StatesPharmaceuticals & BiotechEnterprise
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and raremore
Gartner, Inc. is a prominent global research and advisory firm founded in 1979, with a focus on providing insights and consulting services primarily in information technology (IT). Headquartered in Stamford, Connecticut, Gartner operates over 110 offices in more than 100 countries and employs around 16,000 people. The company reported revenue of $4.25 billion and has a market capitalization of approximately $31.48 billion as of April 2025. Gene Hall has been the CEO since 2004.
Gartner's core offerings include research and advisory services, featuring impactful reports and market analysis tools like the Magic Quadrant and Hype Cycle. The firm provides consulting on IT strategy, digital business operations, and emerging technologies. Over the years, Gartner has expanded its focus beyond IT into areas such as digital transformation and cloud computing, positioning itself as a leading provider in market research. Its client base includes businesses in the IT sector and organizations seeking strategic guidance.